Connect with us

Hi, what are you looking for?

Capital Business
Capital Business
Glaxo in $350mln cancer deal with biotech specialist/AFP

World

China government to probe 60 firms over drug prices

Chinese police are already investigating senior staff of GlaxoSmithKline in China for suspected economic crimes/AFP

Chinese police are already investigating senior staff of GlaxoSmithKline in China for suspected economic crimes/AFP

SHANGHAI, July 4 – China’s top economic planner is to investigate 60 pharmaceutical companies for excessive charges, including several joint ventures with foreign firms, state media reported Thursday.

The National Development and Reform Commission (NDRC), which is already investigating foreign baby formula producers over prices, will send teams to check wholesale prices and production costs of dozens of companies, the Securities Daily said.

In a statement the NDRC said firms targeted in the investigation include Sino-foreign joint ventures with Britain’s GlaxoSmithKline, Germany’s Boehringer Ingelheim and global healthcare firm MSD.

The inquiry will also look at several Chinese companies, among them industry leader Sinopharm Group and Jiangsu Hengrui Medicine, which specialises in anti tumour drugs.

Chinese police are already investigating senior staff of GlaxoSmithKline in China for suspected “economic crimes” but it was unclear whether there was any connection between the two probes.

The NDRC, which helps regulate prices in China, said the four-month survey aimed to “timely set and adjust drug prices”.

Analysts said providing healthcare at affordable prices was a political platform of China’s ruling Communist Party.

“There always has been a lot of pressure to make sure that common drugs are available at very cheap prices relative to what they would be sold for in a lot of Western markets,” said Ben Cavender of the China Market Research Group consultancy.

It is also common practice for Chinese pharmaceutical firms to offer doctors and hospitals bribes to have their products used, industry officials say.

State media reported Tuesday that the NDRC had launched a probe of foreign baby formula makers for high prices resulting from a monopoly like situation.

Advertisement. Scroll to continue reading.

The government agency declined to confirm the reports but companies targeted said they were cooperating.

A unit of Swiss based Nestle, Wyeth Nutrition, responded by slashing its baby formula prices in China by as much as 20 percent, while France’s Danone said it planned to cut prices as well.

 

Click to comment
Advertisement

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...

Headlines

NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...

Kenya

NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...

Coronavirus

NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...

Coronavirus

NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...